TLSI
TriSalus Life Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.00
+0.40%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 39.12x
- P/S forward
- 4.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 47.00x
- Price / sales
- 6.83x
- Price / cash flow
- -10.51x
Enterprise value
- Enterprise value
- $296.0M
- EV / sales
- 6.57x
- EV / EBITDA
- -13.66x
- EV / EBIT
- -9.70x
- Market cap
- $307.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026